中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

309 records (took 0.022 seconds)

    IN-BLOOD COMPONENT MEASUREMENT METHOD, IN-BLOOD COMPONENT MEASUREMENT DEVICE AND IN-BLOOD COMPONENT MEASUREMENT PROGRAM
    82.
    发明申请
    IN-BLOOD COMPONENT MEASUREMENT METHOD, IN-BLOOD COMPONENT MEASUREMENT DEVICE AND IN-BLOOD COMPONENT MEASUREMENT PROGRAM 审中-公开

    公开(公告)号：US20190282139A1

    公开(公告)日：2019-09-19

    申请号：US16345107

    申请日：2017-11-02

    Applicant: Kowa Company, Ltd.

    Inventor： Takaharu ASANO ,  Katsumi YABUSAKI

    IPC: A61B5/145 ,  A61B5/1455

    Abstract: Provided are an in-blood component measurement method, an in-blood component measurement device, and an in-blood component measurement program, enabling more accurate measurement of a proportion of glycohemoglobin in the total hemoglobin concentration in blood. The in-blood component measurement method is designed to have a constitution including the steps of irradiating, with near-infrared light, blood that is a target to be measured for a proportion of glycohemoglobin in the total hemoglobin concentration in blood, receiving transmitted light of the near-infrared light passing through the blood, measuring an absorption spectrum of the blood on the basis of the transmitted light received, and calculating the proportion for the blood that is the target of measurement by comparing absorbance at a first wavelength range including 1450 nm in the measured absorption spectrum to absorbance at the first wavelength range in the absorption spectrum of blood in which the proportion is already known.

    THERAPEUTIC AGENT FOR DYSLIPIDEMIA
    83.
    发明申请
    THERAPEUTIC AGENT FOR DYSLIPIDEMIA 审中-公开

    公开(公告)号：US20190167645A1

    公开(公告)日：2019-06-06

    申请号：US16272050

    申请日：2019-02-11

    Applicant: KOWA COMPANY, LTD.

    Inventor： Toshiaki Takizawa ,  Yasunobu Yoshinaka

    IPC: A61K31/423 ,  A61K45/06 ,  A61K31/397

    Abstract: The present invention addresses the problem of providing a pharmaceutical combination composition and drug combinations for the prevention and/or treatment of dyslipidemic conditions such as atherosclerosis, hypercholesterolemia, low HDL blood disease in mammals including humans. A pharmaceutical composition for the prevention and/or treatment of dyslipidemia, etc. which comprises (a) a compound represented by the general formula (1) (in the formula, each symbol is the same as defined in the specification) or a salt thereof or a solvate thereof and (b) a cholesterol absorption inhibitor.

    PERIMETER
    85.
    发明申请
    PERIMETER 审中-公开

    公开(公告)号：US20190117059A1

    公开(公告)日：2019-04-25

    申请号：US16210038

    申请日：2018-12-05

    Applicant: KOWA COMPANY, LTD.

    Inventor： Satoshi SHIMADA ,  Takuya HARA

    IPC: A61B3/024 ,  A61B3/00

    Abstract: In a perimetry to be conducted, designating an inspection region through a region designator, a perimeter is configured to set a required time of the perimetry (upper limit time) through an upper limit condition setter and to determine total number or positions of stimulus presentation spots based upon the upper limit time. In such a configuration, an examinee knows the time to finish the inspection, and is able to highly keep his (her) concentration in comparison with a case where the required time is not known, thereby improving precision of the inspection.

    Dyslipidemia therapeutic agent
    87.
    发明授权
    Dyslipidemia therapeutic agent 有权

    公开(公告)号：US09968592B2

    公开(公告)日：2018-05-15

    申请号：US15513277

    申请日：2015-09-28

    Applicant: KOWA COMPANY, LTD.

    Inventor： Yuta Inokuchi ,  Haruki Shibata ,  Toshiaki Takizawa

    IPC: A61K31/423 ,  A61K31/4152 ,  A61K45/06 ,  A61K45/00

    CPC classification number: A61K31/423 ,  A61K31/4152 ,  A61K31/421 ,  A61K31/505 ,  A61K45/00 ,  A61K45/06 ,  A61K2300/00

    Abstract: This invention provides a combination-drug composition and a combination use of pharmaceuticals for preventing and/or treating dyslipidemic conditions such as hyper-LDL cholesterolemia in mammals, including humans.This invention pertains to a drug composition for preventing and/or treating dyslipidemia and the like, the drug composition including the following: (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate of either; and (S)-trans-{4-[({2-[({1-[3,5-bis(trifluoromethyl)phenyl]ethyl}{5-[2-(methyl sulfonyl)ethoxy]pyrimidin-2-yl}amino)methyl]-4-(trifluoromethyl)phenyl}(ethyl)amino)methyl]cyclohexyl} acetic acid, a salt thereof, or a solvate of either.

    INTRAOCULAR LENS AND MANUFACTURING METHOD THEREOF
    89.
    发明申请
    INTRAOCULAR LENS AND MANUFACTURING METHOD THEREOF 审中-公开

    公开(公告)号：US20180014927A1

    公开(公告)日：2018-01-18

    申请号：US15718675

    申请日：2017-09-28

    Applicant: KOWA COMPANY, LTD.

    Inventor： Asaki SUZAKI

    IPC: A61F2/16 ,  G02C7/02

    CPC classification number: A61F2/1637 ,  A61F2/1613 ,  A61F2240/001 ,  G02C7/027

    Abstract: Provided is an intraocular lens having a novel structure with high utility which is easy to adapt to patients, and can improve quality of vision (QOV). In an intraocular lens, an optical characteristic is set rotationally symmetric around an optical axis, and a spherical aberration of a size corresponding to a coma aberration remaining in a patient's eye after extraction of a human lens of the eye is set.

    TOMOGRAPHIC IMAGE CAPTURING DEVICE
    90.
    发明申请
    TOMOGRAPHIC IMAGE CAPTURING DEVICE 审中-公开

    公开(公告)号：US20180008144A1

    公开(公告)日：2018-01-11

    申请号：US15553681

    申请日：2016-02-26

    Applicant: KOWA COMPANY, LTD.

    Inventor： Naoki KOBAYASHI ,  Masaharu MIZUOCHI ,  Toshiaki NAKAGAWA

    IPC: A61B3/10 ,  A61B3/14 ,  A61B3/00 ,  G01B9/02

    CPC classification number: A61B3/102 ,  A61B3/0025 ,  A61B3/0041 ,  A61B3/10 ,  A61B3/1025 ,  A61B3/14 ,  G01B9/02091 ,  G06T9/00 ,  H04N19/00

    Abstract: The tomographic image capturing device of the present invention includes a tomographic image capturing means that scans measurement light on a subject's eye fundus (E) to capture tomographic images of the subject's eye fundus and an image processing means that compresses a picture of the captured tomographic images in a scan direction to generate a new tomographic picture. The tomographic image capturing means performs scan at a second scan pitch (PL) narrower than a first scan pitch (PH) to capture the tomographic images of the subject's eye fundus. The image processing means compresses the picture (B11) of the tomographic images captured at the second scan pitch (PL) in the scan direction to generate the new tomographic picture (B12). The measurement width in the scan direction of the new tomographic picture (B12) is a width of a picture corresponding to a measurement width in the scan direction of a tomographic picture (Bn (n=1 to 10)) obtained by scan at the first scan pitch (PH).

Patent Agency Ranking